ArticleFrontiers in neurology2025

Dexmedetomidine reduces in-hospital mortality in aneurysmal subarachnoid hemorrhage patients by modulating three key genes and inflammatory pathways: insights from clinical and bioinformatics analyses.

Zhi-Ang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.